← Leaderboards
Narasimham Laxmi Parinandi
Ohio State University
$753,350
Attributed
$1,506,700
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $381.3K · FY2010–13$500K$375K$250K$125K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$1,506,700 · 1
By mechanism
R01$1,506,700 · 1
Top collaborators
- Ulysses J Magalang4 shared
Most similar at Ohio State University
Same institution · by research overlap
- Veronique A Lacombe$1,609,046
- Rami N Khayat$1,720,365
- Lawrence S Kirschner$10,043,463
- Arturo J Cardounel$2,710,412
- Uma Sundaram$12,768,461
Others in their field
Top investigators on “Adiponectin”
- Leonardo Trasande · New York University School Of Medicine$51,045,834
- Philipp E Scherer · Ut Southwestern Medical Center$28,064,635
- Charles S Fuchs · Brigham And Women'S Hospital$12,539,853
- Frank B Hu · Harvard University D/B/A Harvard School Of Public Health$11,239,481
- Edward Giovannucci · Brigham And Women'S Hospital$10,646,817
- Lu Qi · Tulane University Of Louisiana$10,643,820
Research focus
AdiponectinAdipose TissueAffectAirway ObstructionAnimal ModelAnimalsAntiatherogenicAntidiabetic DrugsAnti-InflammatoryAnti-Inflammatory AgentsAttentionAttenuationAuthorityBiologyCardiacCardiomyopathiesCardiovascular DiseasesCardiovascular Risk FactorCellsCollegeCongestive Heart FailureContinuous Positive Airway PressureCoupledAdipocytes
Grant awards (4)
Intermittent hypoxia, adiponectin, and insulin resistance in cardiovascular risk$362,950
R01 · FY2013 · HL · contact PI
Intermittent hypoxia, adiponectin, and insulin resistance in cardiovascular risk$381,250
R01 · FY2012 · HL · contact PI
Intermittent hypoxia, adiponectin, and insulin resistance in cardiovascular risk$381,250
R01 · FY2011 · HL · contact PI
Intermittent hypoxia, adiponectin, and insulin resistance in cardiovascular risk$381,250
R01 · FY2010 · HL · contact PI